Meeting
2022 ASCO Annual Meeting
Elranatamab, a BCMA-targeted T-cell redirecting immunotherapy, for patients with relapsed or refractory multiple myeloma: Updated results from MagnetisMM-1.
Authors
Andrzej J. Jakubowiak
Department of Medicine, University of Chicago Medical Center, Chicago, IL
Andrzej J. Jakubowiak , Nizar J. Bahlis , Noopur S. Raje , Caitlin Costello , Bhagirathbhai R. Dholaria , Melhem M. Solh , Moshe Y. Levy , Michael H Tomasson , Harman Dube , Michael A. Damore , Sibo Jiang , Cynthia Basu , Athanasia Skoura , Edward Michael Chan , Suzanne Trudel , Michael P Chu , Cristina J. Gasparetto , Andrew Peter Dalovisio , Michael Sebag , Alexander M. Lesokhin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT03269136
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8014)
DOI
10.1200/JCO.2022.40.16_suppl.8014
Abstract #
8014
Poster Bd #
438
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Baseline and early post-infusion biomarkers associated with optimal response to idecabtagene vicleucel (ide-cel) in the KarMMa-3 study of triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM).
First Author: Julia Piasecki
Poster
2019 ASCO Annual Meeting
Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma.
First Author: William Bensinger
Poster
2023 ASCO Annual Meeting
OMNIA-2: Phase I/II study of ANV419, an IL-2R-βγ targeted antibody-IL-2 fusion protein, in patients with relapsed or refractory multiple myeloma.
First Author: Dagmar Hess
Poster
2023 ASCO Annual Meeting
Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.
First Author: Nabila Nora Bennani